Long-term continuous intraperitoneal insulin treatment in brittle diabetes.

G. Pozza, Donatella Spotti, P. Micossi, M. Cristallo, M. Melandri, Pier Marco Piatti, Lucilla D. Monti, Antonio E. Pontiroli

BMJ · 1983 · 27 citations · 3 references

DOIFull text

Open access

Concepts

Abstract

Attempts to achieve a fair metabolic equilibrium in a young woman with brittle diabetes by continuous subcutaneous, intramuscular, and continuous intravenous administration of insulin were unsuccessful. Continuous intraperitoneal administration of insulin through a permanently inserted polyethylene catheter connected to an open-loop peristaltic pump led to an appreciable improvement in mean blood glucose concentration, mean amplitude of glycaemic excursions, and M value and to normalisation of intermediate metabolic products. The peritoneal catheter was well tolerated for over 120 days without appreciable adverse effects. This case suggests that long-term intraperitoneal administration of insulin is a feasible therapeutic approach in the management of brittle diabetes.

References

3